Kilitch Drugs India Profit & Loss Annual

BSE: 524500 | NSE: KILITCH | ISIN: INE729D01010 | Sector: Biotechnology & Drugs

306.60 -2.45 (-0.79%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	154.37	139.60	114.23	68.52
Total Revenue	154.37	139.60	114.23	68.52
Costof Revenue Total	92.91	90.71	75.04	44.24
Gross Profit	61.46	48.89	39.20	24.28
Selling/ General/ Admin Expenses Total	10.01	30.32	22.57	18.60
Depreciation/ Amortization	3.35	3.55	2.47	1.99
Other Operating Expenses Total	27.29	1.00	5.54	0.47
Total Operating Expense	133.57	125.58	105.61	65.29
Operating Income	20.81	14.02	8.62	3.23
Interest Inc( Exp) Net- Non- Op Total	-59.29	-25.88	7.29	17.08
Other Net	4.48	0.59	0.26	0.18
Net Income Before Taxes	19.35	12.01	9.61	5.12
Provisionfor Income Taxes	5.78	3.73	3.40	1.35
Net Income After Taxes	13.58	8.28	6.21	3.77
Minority Interest	1.03	2.17	1.15	-0.10
Net Income Before Extra Items	14.60	10.45	7.37	3.67
Net Income	14.60	10.45	7.37	3.67
Income Availableto Com Excl Extra Ord	14.60	10.45	7.37	3.67
Income Availableto Com Incl Extra Ord	14.60	10.45	7.37	3.67
Diluted Net Income	14.60	10.45	7.37	3.67
Diluted Weighted Average Shares	1.59	1.56	1.56	1.55
Diluted EPS Excluding Extra Ord Items	9.17	6.71	4.73	2.37
Diluted Normalized EPS	9.17	7.25	5.27	2.37
Total Adjustmentsto Net Income	-	-	0.00	-